116 related articles for article (PubMed ID: 1438448)
21. [Application of IHW2 purged bone marrow to autologous bone marrow transplantation in the treatment of acute myeloid leukemia].
Jiang R; Han M; Zhao Y
Zhonghua Xue Ye Xue Za Zhi; 1998 Jun; 19(6):312-4. PubMed ID: 11243113
[TBL] [Abstract][Full Text] [Related]
22. Autologous bone marrow transplantation for acute myeloid leukemia using 4-hydroperoxycyclophosphamide-purged bone marrow and the busulfan/etoposide preparative regimen: a follow-up report.
Linker CA; Ries CA; Damon LE; Rugo HS; Wolf JL
Bone Marrow Transplant; 1998 Nov; 22(9):865-72. PubMed ID: 9827814
[TBL] [Abstract][Full Text] [Related]
23. Autologous bone marrow transplantation for adult acute leukemia.
Ball ED; Rybka WB
Hematol Oncol Clin North Am; 1993 Feb; 7(1):201-31. PubMed ID: 8449859
[TBL] [Abstract][Full Text] [Related]
24. Autologous bone marrow transplantation for acute lymphoblastic leukemia: role of bone marrow purging.
Canals C; Picón M; Sanchez T; Torrico C; Amill B; Tugues D; Sierra J; Grañena A; Badell I; Brunet S
Prog Clin Biol Res; 1994; 389():125-32. PubMed ID: 7700894
[No Abstract] [Full Text] [Related]
25. Long-term culture of autologous bone marrow for marrow reconstitution following high-dose chemotherapy. Purging with tumor surface antigen directed human-human monoclonal antibody.
Alonso K; Medenica R; Morehead G
Prog Clin Biol Res; 1994; 389():111-8. PubMed ID: 7700892
[No Abstract] [Full Text] [Related]
26. Allogeneic bone marrow transplantation for the treatment of adult acute leukemias.
Christiansen NP
Hematol Oncol Clin North Am; 1993 Feb; 7(1):177-200. PubMed ID: 8449858
[TBL] [Abstract][Full Text] [Related]
27. A phase II trial of autologous bone marrow transplantation (ABMT) in acute leukemia with edelfosine purged bone marrow.
Vogler WR; Berdel WE; Geller RB; Brochstein JA; Beveridge RA; Dalton WS; Miller KB; Lazarus HM
Adv Exp Med Biol; 1996; 416():389-96. PubMed ID: 9131178
[TBL] [Abstract][Full Text] [Related]
28. Removal of breast cancer cells from bone marrow by in vitro purging with ether lipids and cryopreservation.
Dietzfelbinger HF; Kühn D; Zafferani M; Hanauske AR; Rastetter JW; Berdel WE
Cancer Res; 1993 Aug; 53(16):3747-51. PubMed ID: 8339286
[TBL] [Abstract][Full Text] [Related]
29. Autologous bone marrow transplantation with negative immunomagnetic purging for aggressive B-cell non-Hodgkin's lymphoma in first complete remission.
De Rosa L; Lalle M; Pandolfi A; Ruscio C; Amodeo R
Ann Hematol; 2002 Oct; 81(10):575-81. PubMed ID: 12424539
[TBL] [Abstract][Full Text] [Related]
30. Role of autologous bone marrow transplantation for patients with acute and chronic leukemias.
Geller RB
Hematol Oncol Clin North Am; 1993 Jun; 7(3):547-75. PubMed ID: 8344882
[TBL] [Abstract][Full Text] [Related]
31. Detection of minimal residual disease in patients with childhood common acute lymphoblastic leukemia after autologous bone marrow transplantation with ex vivo purging and systemic IL-2 infusion: unsuccessful prediction of subsequent relapse.
Kiyoi H; Kojima S; Kato K; Matsuyama T; Kodera Y; Ohno R; Naoe T
Bone Marrow Transplant; 1995 Sep; 16(3):437-42. PubMed ID: 8535317
[TBL] [Abstract][Full Text] [Related]
32. Bone marrow purging with antisense oligodeoxynucleotides.
Gewirtz AM
Prog Clin Biol Res; 1992; 377():215-24; discussion 225-6. PubMed ID: 1438418
[No Abstract] [Full Text] [Related]
33. Purging multidrug resistant cells from bone marrow.
Chao NJ; Aihara M; Kühl JS; Sikic BI; Blume KG
Prog Clin Biol Res; 1992; 377():13-23. PubMed ID: 1438409
[No Abstract] [Full Text] [Related]
34. Melphalan-total body irradiation and autologous bone marrow transplantation for adult acute leukemia beyond first remission.
Mehta J; Powles R; Singhal S; Horton C; Tait D; Treleaven J
Bone Marrow Transplant; 1996 Jul; 18(1):119-23. PubMed ID: 8832004
[TBL] [Abstract][Full Text] [Related]
35. Bone marrow-resident memory T cells survive pretransplant chemotherapy and contribute to early immune reconstitution of patients with acute myeloid leukemia given mafosfamide-purged autologous bone marrow transplantation.
Casorati G; Locatelli F; Pagani S; Garavaglia C; Montini E; Lisini D; Turin I; Rossi F; Dellabona P; Maccario R; Montagna D
Exp Hematol; 2005 Feb; 33(2):212-8. PubMed ID: 15676215
[TBL] [Abstract][Full Text] [Related]
36. Autologous bone marrow transplantation in acute myeloid leukemia in relapse or in complete remission.
Herve P; Rozenbaum A; Plouvier E; Flesch M; Cahn JY; Farradji A; Bergerat JP; Adjizian JC; Pignon B
Cancer Treat Rep; 1982 Nov; 66(11):1983-5. PubMed ID: 6754076
[TBL] [Abstract][Full Text] [Related]
37. [Acute leukemia: autologous transplantation of bone marrow cells grown in long-term culture containing low molecular weight natural tumour suppressor].
Yang K; Teng AP; Pei ZT
Zhonghua Yi Xue Za Zhi; 1994 May; 74(5):287-9, 325-6. PubMed ID: 7953919
[TBL] [Abstract][Full Text] [Related]
38. Role of autologous bone marrow transplantation as consolidation therapy in acute promyelocytic leukemia patients in complete remission.
Ottaviani E; Martinelli G; Testoni N; Visani G; Tani M; Tura S
Haematologica; 1998 Nov; 83(11):1051-5. PubMed ID: 9864933
[TBL] [Abstract][Full Text] [Related]
39. Antisense oligonucleotide OL (1) p53 for in vitro purging of autologous bone marrow in acute myelogenous leukemia.
Bishop MR; Warkentin PI; Jackson JD; Bayever E; Iversen PL; Whalen VI; Lastovica J; Haines K; Kessinger A
Prog Clin Biol Res; 1994; 389():183-7. PubMed ID: 7700901
[No Abstract] [Full Text] [Related]
40. The sensitivity of leukemic bone marrow to simvastatin is lost at remission: a potential purging agent for autologous bone marrow transplantation.
Newman A; Clutterbuck RD; DeLord C; Powles RL; Catovsky D; Millar JL
J Investig Med; 1995 Jun; 43(3):269-74. PubMed ID: 7614073
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
